Globus Medical, Inc. GMED
74.52
0.25
0.34%
as of 25 Sep
- Market cap
- $10.0B
- P/E
- 18.8×
Follow GMED
Growth Flags
show if company had growth for consecutive years
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| 11.81% | 13.30% | 12.29% | 10.01% |
+8 more TTM periods Free account |
|
| 10.25% | 11.56% | 10.19% | 8.32% | ||
ROIC |
9.58% | 8.12% | 7.47% | 5.78% | |
Return on Tangible Assets |
23.59% | 25.81% | 24.54% | 20.81% | |
Average Days of Receivables |
85.80 | 86.57 | 92.36 | 90.68 | |
Free Cash Flow per Share |
5.59 | 4.51 | 4.21 | 4.16 | |
Free Cash Flow |
755.59 | 610.32 | 569.02 | 559.94 | |
Capital Expenditures |
(154.80) | (168.19) | (184.42) | (155.26) | |
Piotroski F-Score |
7.00 | 7.00 | 8.00 | 8.00 | |
| Other line items | |||||
Cash ROIC |
16.97% | 14.52% | 14.69% | 14.93% | |
Accounts Receivable Turnover |
4.49 | 4.87 | 4.45 | 4.32 | |
Accounts Payable Turnover |
10.20 | 11.27 | 11.01 | 13.26 | |
Inventory Turnover |
1.25 | 1.39 | 1.35 | 1.29 | |
Average Days of Payables |
39.46 | 37.97 | 37.67 | 33.16 | |
Days of Inventory on Hand |
299.23 | 283.00 | 289.35 | 293.30 | |
Tax Rate |
(0.19) | (0.11) | (0.11) | (0.08) | |
Research and Development Expense of Revenue |
4.68% | 4.86% | 5.01% | 5.22% | |
Selling, General and Administrative Expense of Revenue |
38.69% | 39.78% | 40.10% | 40.19% | |
Share Based Compensation of Revenue |
1.56% | 1.59% | 1.69% | 1.81% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
1.70 | 1.33 | 1.40 | 1.69 | |
Depreciation/Fixed assets |
0.55 | 0.54 | 0.54 | 0.60 | |
Capex/Depreciation |
(0.53) | (0.56) | (0.61) | (0.45) | |
Revenue per Share |
23.29 | 22.91 | 21.74 | 20.59 | |
Operating CF per Share |
6.74 | 5.75 | 5.57 | 5.32 | |
Capex per Share |
(1.15) | (1.24) | (1.36) | (1.15) | |
Capex to Sales |
0.05 | 0.05 | 0.06 | 0.06 | |
Net Profit Margin |
17.03% | 18.92% | 18.30% | 15.30% |
Columns are period end dates